PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 260 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $218,503 | -35.0% | 7,122 | -18.1% | 0.00% | 0.0% |
| Q4 2022 | $335,946 | -38.7% | 8,701 | -15.5% | 0.00% | 0.0% |
| Q3 2022 | $548,000 | +36.0% | 10,297 | +48.9% | 0.00% | 0.0% |
| Q2 2022 | $403,000 | -57.8% | 6,916 | -44.8% | 0.00% | -66.7% |
| Q1 2022 | $956,000 | +77.7% | 12,528 | +39.8% | 0.00% | +50.0% |
| Q4 2021 | $538,000 | -59.0% | 8,961 | -58.6% | 0.00% | -60.0% |
| Q2 2021 | $1,312,000 | +94.4% | 21,631 | +45.2% | 0.01% | 0.0% |
| Q4 2019 | $675,000 | +115.0% | 14,900 | +105.9% | 0.01% | +150.0% |
| Q2 2019 | $314,000 | -48.3% | 7,236 | -48.7% | 0.00% | -50.0% |
| Q4 2018 | $607,000 | -86.2% | 14,100 | -84.2% | 0.00% | -82.6% |
| Q3 2018 | $4,394,000 | +3720.9% | 89,400 | +3623.4% | 0.02% | +2200.0% |
| Q2 2017 | $115,000 | -55.8% | 2,401 | -57.9% | 0.00% | -50.0% |
| Q1 2017 | $260,000 | -74.9% | 5,700 | -82.2% | 0.00% | -71.4% |
| Q4 2016 | $1,036,000 | +5994.1% | 32,077 | +6302.6% | 0.01% | – |
| Q3 2016 | $17,000 | -79.8% | 501 | -54.5% | 0.00% | -100.0% |
| Q4 2015 | $84,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |